Evolution of the Average Target: Vivendi SE

Evolution of the Average Target - Vivendi SE

Evolution of the Target Price: Vivendi SE

Evolution of the Target Price - Vivendi SE

Changes in Analyst Recommendations: Vivendi SE

25a1d82c6338c9c67cb.ElOc51p0qQRckjwMw8QMQmYQ6-8mqy8YzpQsAcstbpw.Zhr6ygIcmk494lVdsLY-cC5lobtN0lwhhfhCTf9fF98jaua2N0LvMRvNXw~52f801cf074b430c940c82533fedbb27
09-09 Deutsche Bank cuts its target on Vivendi Zonebourse
09-04 Volkswagen shifts into second gear, with Porsche in its wake. Vivendi disappoints Zonebourse
09-03 Vivendi: Mixed H1 '26 results with no deleveraging Alphavalue
07-10 Vivendi: EPS upgrade (2026: +343.0%, 2027: +1.6%) Alphavalue
05-29 Vivendi takeover unlikely to rest on an internal email Alphavalue
04-21 Vivendi: A difficult start to the year with limited highlights Alphavalue
04-10 Robertet follows its nose, Sodexo loses its appetite Zonebourse
04-07 Vivendi: UMG/Pershing Square: US listing disguised as a merger Alphavalue
03-24 AlphaValue/Baader Europe Cuts Vivendi EPS Forecasts on Net Income Miss; Price Target Up MT
03-23 Vivendi: Target upgrade by 11.5% Alphavalue
03-12 Vivendi: Continued good progress on cost cutting and deleveraging Alphavalue
11-28 Vivendi takeover prospects dim after French Supreme Court ruling Alphavalue
11-21 AlphaValue Downgrades Recommendation on Vivendi Shares Zonebourse
11-21 Vivendi Down to Reduce from Buy as AlphaValue/Baader Europe Says Bolloré Takeover Prospects 'Nil' MT
11-20 Vivendi faces reduced rating as takeover hopes fade Alphavalue
11-19 Vivendi share slide deepens as mandatory takeover prospects fade Alphavalue
25-10-22 Vivendi: Useless Q3 results Alphavalue
25-10-21 Vivendi nine months revenue at EUR 213 million RE
25-08-08 Update on Recommendation Changes in Paris RE
25-07-31 Vivendi: Good progress on cost cutting and deleveraging Alphavalue
25-07-29 Vivendi: New elements in the Bolloré/Vivendi saga Alphavalue
25-07-21 Vivendi: NAV cut by -2.9% Alphavalue
25-07-18 Vivendi: Increased likelihood of European Commission fine, but investment case remains appealing Alphavalue
25-07-18 A welcomed AMF decision that improves an already very appealing investment case Alphavalue
25-04-28 Vivendi: A good start to the year for Vivendi Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+48.25%
+17.55%
+51.78%
+6.75%
+36.95%
+31.15%
+9.91%
+4.14%
+19.55%
+13.22%
Average +23.93%
Weighted average by Cap. +23.79%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
1.424EUR
Average target price
2.121EUR
Spread / Average Target
+48.98%
High Price Target
3.000EUR
Spread / Highest target
+110.67%
Low Price Target
1.700EUR
Spread / Lowest Target
+19.38%

Analyst Consensus Detail

Analyst consensus - Vivendi SE

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Vivendi SE
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - Vivendi SE
  1. Stock Market
  2. Stocks
  3. VIV Stock
  4. Consensus Vivendi SE